Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease.


Journal

Alzheimer's & dementia (New York, N. Y.)
ISSN: 2352-8737
Titre abrégé: Alzheimers Dement (N Y)
Pays: United States
ID NLM: 101650118

Informations de publication

Date de publication:
2019
Historique:
entrez: 1 1 2020
pubmed: 1 1 2020
medline: 1 1 2020
Statut: epublish

Résumé

After the midninth decade of age, the incidence rates of Alzheimer's disease (AD) and the presence of active TGF-β1 show comparable increases. The hypothesis is proposed that the reason why advanced age is a major risk factor for AD is a progressive decrease with advancing age in the numbers of TGFR2 receptors in the brain, with the consequence of a decline in the neurotrophic efficacy of TGF-β1 and 2 despite their already increased levels in older persons. Alternative, possible reasons are discussed but rejected because either those reasons may also affect young persons or because they cannot be validated in a clinical trial. The proposed hypothesis may be validated in persons with aMCI after raising their brain levels of TGF-β1 and 2 by using a combination of three drugs, lithium, memantine, plus either glatiramer or venlafaxine, and then assessing their progression to AD.

Identifiants

pubmed: 31890854
doi: 10.1016/j.trci.2019.11.007
pii: S2352-8737(19)30093-9
pmc: PMC6926356
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

899-905

Informations de copyright

© 2019 The Authors.

Références

Neurobiol Aging. 2002 Mar-Apr;23(2):237-43
pubmed: 11804709
Biol Psychiatry. 2010 Nov 15;68(10):930-41
pubmed: 20692646
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11472-7
pubmed: 11027347
Diabetes. 2016 Oct;65(10):2849-61
pubmed: 27358493
J Neuropathol Exp Neurol. 2006 Apr;65(4):358-70
pubmed: 16691117
CNS Neurosci Ther. 2011 Aug;17(4):237-49
pubmed: 19925479
Neuropharmacology. 2016 Aug;107:131-145
pubmed: 26965219
JAMA. 2001 Feb 14;285(6):739-47
pubmed: 11176911
Neuropathology. 2006 Aug;26(4):307-12
pubmed: 16961066
J Clin Invest. 1996 Oct 1;98(7):1642-9
pubmed: 8833914
J Clin Invest. 1997 Jun 15;99(12):2842-50
pubmed: 9185506
Neurosci Lett. 2004 Sep 2;367(2):194-6
pubmed: 15331151
Brain Res. 2010 Oct 21;1357:166-74
pubmed: 20709030
J Am Geriatr Soc. 1998 Jul;46(7):833-8
pubmed: 9670869
Neurobiol Dis. 2009 Mar;33(3):422-8
pubmed: 19110058
Front Aging Neurosci. 2015 Jul 20;7:124
pubmed: 26257642
Aging Cell. 2004 Dec;3(6):443-8
pubmed: 15569360
Mech Ageing Dev. 2003 Apr;124(4):487-93
pubmed: 12714257
Clin Infect Dis. 1994 Dec;19(6):1158-9
pubmed: 7888553
Clin Diagn Lab Immunol. 1994 Jul;1(4):433-6
pubmed: 8556481
Am J Pathol. 2006 Jul;169(1):154-64
pubmed: 16816369
Mol Endocrinol. 1992 Jan;6(1):15-25
pubmed: 1738367
Aging Cell. 2004 Aug;3(4):169-76
pubmed: 15268750
J Mol Psychiatry. 2016 Jul 15;4:3
pubmed: 27429752
Mol Neurobiol. 2019 Sep;56(9):6156-6167
pubmed: 30734227
J Gerontol A Biol Sci Med Sci. 1997 Mar;52(2):M117-25
pubmed: 9060980
Cell Death Dis. 2014 Feb 13;5:e1054
pubmed: 24525730
Clinics (Sao Paulo). 2011;66(7):1143-7
pubmed: 21876965
Am J Alzheimers Dis Other Demen. 2017 May;32(3):166-181
pubmed: 28423937
Brain Behav Immun. 2014 Mar;37:187-96
pubmed: 24380849
Neurol Sci. 2006 Apr;27(1):33-9
pubmed: 16688597
Nat Neurosci. 2014 Jan;17(1):131-43
pubmed: 24316888
J Neuroinflammation. 2011 Dec 07;8:171
pubmed: 22152162
Clin Cancer Res. 1998 Jul;4(7):1625-30
pubmed: 9676836
J Gerontol A Biol Sci Med Sci. 2016 Aug;71(8):1069-73
pubmed: 27091133
Dis Markers. 2005;21(2):71-4
pubmed: 15920293
Dis Markers. 2009;27(1):23-8
pubmed: 19822955
PLoS One. 2011;6(12):e29610
pubmed: 22216330
Exp Neurol. 2012 Jun;235(2):436-46
pubmed: 21945006
Arch Gen Psychiatry. 1998 Sep;55(9):809-15
pubmed: 9736007
Aging (Albany NY). 2011 Feb;3(2):108-24
pubmed: 21386132
Psychiatry Investig. 2012 Jun;9(2):166-73
pubmed: 22707968
Clin Exp Immunol. 1999 Sep;117(3):476-81
pubmed: 10469050
J Biol Chem. 2003 Oct 31;278(44):43329-39
pubmed: 12888549
Nature. 1997 Dec 4;390(6659):465-71
pubmed: 9393997
Elife. 2019 May 09;8:
pubmed: 31071011
Biochem Pharmacol. 2014 Apr 15;88(4):594-604
pubmed: 24445162
Nature. 2008 Jul 3;454(7200):56-61
pubmed: 18548003
J Clin Invest. 2006 Nov;116(11):3060-9
pubmed: 17080199
Neuroscience. 2001;105(4):853-62
pubmed: 11530223
Sci Rep. 2018 Jan 15;8(1):737
pubmed: 29335583
Ann Neurol. 2004 Feb;55(2):180-5
pubmed: 14755721
J Cell Mol Med. 2014 Jul;18(7):1444-59
pubmed: 24779367

Auteurs

Jeffrey Fessel (J)

Emeritus, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Classifications MeSH